Table 1. Demographic and baseline characteristics.
| Variables | ENI (n = 19) |
Non ENI (n = 19) |
P Value |
|---|---|---|---|
| Demographics | |||
| Age, years, mean ± standard deviation | 65.4±9.21 | 68.4±14.86 | 0.452 |
| Gender, male, n (%) | 7(36.8) | 8(42.1) | 0.740 |
| Current smoking, n (%) | 8(42.1) | 11(57.9) | 0.330 |
| Alcohol consumption, n (%) | 5(26.3) | 6(31.6) | 0.721 |
| Medical history, n (%) | |||
| Stroke | 3(15.8) | 4(21.1) | 0.676 |
| Hypertension | 10(52.6) | 10(52.6) | 1.000 |
| Diabetes mellitus | 5(26.3) | 5(26.3) | 1.000 |
| Atrial fibrillation | 4(21.1) | 4(21.1) | 1.000 |
| Congestive heart failure | 3(15.8) | 4(21.1) | 0.676 |
| Previous use of antiplatelet | 2(10.5) | 3(15.8) | 0.631 |
| Baseline scales, mean ± standard deviation | |||
| Systolic blood pressure, mmHg | 158.8±24.63 | 153.0±25.09 | 0.478 |
| Diastolic blood pressure, mmHg | 87.3±9.68 | 90.0±15.95 | 0.527 |
| Blood glucose, mmol/L | 9.19±4.68 | 7.68±2.92 | 0.276 |
| Symptom onset to thrombolysis time, min | 160.1±49.11 | 157.0±53.87 | 0.854 |
| NIHSS score at admission | 9.4±5.69 | 8.1±5.65 | 0.462 |
| TOAST classification, n (%) | 0.185 | ||
| Large artery atherosclerosis | 11(57.9) | 10(52.6) | |
| Small artery occlusion | 5(26.3) | 4(21.1) | |
| Cardiogenic embolism | 1(5.3) | 5(26.3) | |
| Undetermined cause | 2(10.5) | 0(0.0) |
ENI, early neurologic improvement; NIHSS, National Institute of Health Stroke Scale; TOAST, the Trial of Org 10172 in Acute Stroke Treatment.